Search

everythinglearnresearchcommunity

for

Search:↓

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Modified Changfa Zirong Powder improves hair growth in androgenetic alopecia.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

A new compound that could treat various androgen-related conditions was created and analyzed.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

Gene variation affects prostate issues and hair loss.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Centipeda minima and brevilin A protect skin cells from damage and aging.

The model and estimator can predict drug exposure in kidney transplant patients well.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Low testosterone increases kidney stone risk in men not on testosterone therapy.